Concentrix (NASDAQ:CNXC – Get Free Report) is expected to issue its Q2 2026 results after the market closes on Monday, June 29th. Analysts expect Concentrix to post earnings of $2.64 per share and revenue of $2.4739 billion for the quarter. Individuals may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Monday, June 29, 2026 at 5:00 PM ET.
Concentrix (NASDAQ:CNXC – Get Free Report) last released its earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.65 by ($0.04). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. During the same period last year, the firm posted $2.79 EPS. Concentrix’s quarterly revenue was up 5.4% compared to the same quarter last year. On average, analysts expect Concentrix to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.
Concentrix Price Performance
Shares of NASDAQ:CNXC opened at $25.07 on Monday. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of -1.16, a P/E/G ratio of 0.31 and a beta of 0.43. The firm has a fifty day moving average price of $26.32 and a 200 day moving average price of $32.63. Concentrix has a fifty-two week low of $22.05 and a fifty-two week high of $62.14. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.18 and a current ratio of 1.18.
Concentrix Announces Dividend
Insider Activity at Concentrix
In related news, CFO Andre S. Valentine purchased 2,500 shares of the stock in a transaction that occurred on Thursday, April 9th. The stock was bought at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the transaction, the chief financial officer directly owned 89,066 shares in the company, valued at $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of Concentrix stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the transaction, the insider directly owned 2,773,667 shares of the company’s stock, valued at $61,714,090.75. The trade was a 68.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.90% of the stock is owned by company insiders.
Hedge Funds Weigh In On Concentrix
A number of large investors have recently made changes to their positions in CNXC. Geneos Wealth Management Inc. lifted its stake in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the last quarter. Larson Financial Group LLC grew its stake in shares of Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares during the last quarter. Global Retirement Partners LLC raised its holdings in shares of Concentrix by 1,032.5% in the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after buying an additional 795 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Concentrix in the third quarter worth approximately $69,000. Finally, Osaic Holdings Inc. lifted its stake in shares of Concentrix by 13.4% during the 2nd quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock worth $118,000 after acquiring an additional 263 shares during the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CNXC has been the topic of several research reports. Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Barrington Research cut their price target on Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a report on Wednesday, March 25th. Canaccord Genuity Group reduced their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, March 25th. Finally, Robert W. Baird decreased their price objective on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a report on Wednesday, March 25th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Concentrix has a consensus rating of “Hold” and a consensus price target of $48.50.
View Our Latest Research Report on Concentrix
Concentrix Company Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Read More
- Five stocks we like better than Concentrix
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
